Storia in 2 fonti

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro - The Korea Times

Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...

Raccontata da

koreaherald.com

koreatimes.co.kr

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

koreatimes.co.krStai leggendo1 mesi fa

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro - The Korea Times

Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...

originale

koreaherald.com1 mesi fa

Samsung Bioepis launches first biosimilar in Japan

Samsung Bioepis said Wednesday it has launched autoimmune disease treatment SB17 in partnership with Nipro Corporation, marking the company’s first product laun

Leggi questa versione → originale

Timeline cronologica

mercoledì 20 maggio 2026·koreaherald.com
Samsung Bioepis launches first biosimilar in Japan
Samsung Bioepis said Wednesday it has launched autoimmune disease treatment SB17 in partnership with Nipro Corporation, marking the company’s first product laun
mercoledì 20 maggio 2026·koreatimes.co.kr
Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro - The Korea Times
Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...